FIELD: chemistry.
SUBSTANCE: invention relates to (17S)-N-benzyl-5-((3β-acetoxy-28-nor-urs-12-ene)-17-yl)-1,3,4-oxadiazole-2-amine of structural formula 1.
EFFECT: technical result: (17S)-N-benzyl-5-((3β-acetoxy-28-nor-urs-12-ene)-17-yl)-1,3,4-oxadiazol-2-amine, having cytotoxic activity on cancer cells of mammary gland MCF-7 and low-toxic with respect to healthy human cells.
1 cl, 1 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ((3Β-ACETOXY-URS-12-EN-28-OYL-OXYACETOXY)METHYL)-1H-1,2,3-TRIAZOL-1-YL)METHYL)-4-METHYL-1,2,5-OXADIAZOL-2-OXIDE, HAVING SELECTIVE ANTICANCER ACTIVITY AGAINST MCF-7 BREAST CANCER CELLS | 2020 |
|
RU2739559C1 |
| DRUG WITH ANTI-INFLAMMATORY ACTIVITY | 2016 |
|
RU2617123C1 |
| HYBRID DERIVATIVES OF URSOLIC ACID AND GALLIC ACID COMPRISING 1,2,3-TRIAZOLE LINKERS WITH ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2802957C1 |
| PHOSPHORYL SUBSTITUTED 3-KETO-ANDROST-4-ENE-[16,17-D]PYRIDAZINES AND METHOD OF THEIR PREPARATION | 2023 |
|
RU2807870C1 |
| N-[3-OXOLUP-20(29)-ENE-28-OIL]-2,2,6,6-TETRAMETHYLPIPERIDINE-4-YLAMINE WITH CYTOTOXIC ACTIVITY IN RESPECT OF HUMAN TUMOUR CELLS | 2017 |
|
RU2641900C1 |
| AGENT FOR INHIBITING HUMAN ENZYME TYROSYL-DNA-PHOSPHODIESTERASE 1 BASED ON PHENYLCOUMARINES, SENSITIZING TUMORS TO ANTITUMOUR AGENTS | 2019 |
|
RU2724878C1 |
| 7-TRIAZOLYL-SUBSTITUTED HYDROXYSPYROSTANES WITH CYTOTOXIC ACTIVITY AGAINST HUMAN TUMOR CELLS | 2023 |
|
RU2798105C1 |
| HYBRID DERIVATIVE OF LUPANE TRITERPENOID AND GALLIC ACID CONTAINING A 1,2,3-TRIAZOLE LINKER WITH ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2811236C1 |
| 24-DIBROM-4-OXO-2-CYANO-3,23-DINOLUP-28-OIC ACID METHYL ETER WITH CYTOTOXIC ACTIVITY | 2022 |
|
RU2784317C1 |
| METHYL ESTERS 3-METHYL-3-OXO-1-CYANO-2,3-SECO-2-NORLUP-20(29)-ENE-30-AL-28 AND 3-BROMETHYLENE-3-OXO-1-CYANO -2,3-SECO-2-NORLUP-20(29)-ENE-30-AL-28 ACIDS WHICH EXHIBIT CYTOTOXIC ACTIVITY | 2016 |
|
RU2632002C1 |
